Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence.

European heart journal

Volumn 33, Issue 14, 2012, Pages 1724-1733

  Spoladore, Roberto ^a   Maron, Martin S ^b   D'Amato, Rossella ^b   Camici, Paolo G ^b   Olivotto, Iacopo ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CARDIOVASCULAR AGENT;

DRUG COMBINATION; DRUG SCREENING; EVIDENCE BASED MEDICINE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FIBROSIS; HEART ATRIUM FIBRILLATION; HEART MUSCLE; HEART OUTFLOW TRACT OBSTRUCTION; HUMAN; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CARDIOVASCULAR AGENTS; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FIBROSIS; HUMANS; MYOCARDIUM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84867151300     PISSN: None     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs150     Document Type: Review

References (0)